未登录

E

Emily D. Parker

The Lewin Group

H指数:28

被引数:3,813

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of Reduced Restrictions in Scope of Practice of Nurse Anesthetists on Patient Safety across States

各州麻醉护士执业范围限制减少对患者安全的影响

Journal of Nursing Regulation

IF6.3

2025-11-100

PRE

Impact of Scope of Practice Laws for Certified Registered Nurse Anesthetists on the Utilization of Anesthesia Services

执业范围法规对认证注册麻醉护士麻醉服务利用率的影响

Health Services Research

IF3.2

2025-10-150

OAAI

Repurposing Ketamine in the Therapy of Depression and Depression-Related Disorders: Recent Advances and Future Potential

AGING AND DISEASE

IF6.9

2024-01-012

OAAI

Economic Costs of Diabetes in the US in 2022

美国2022年糖尿病的经济成本

IF16.6

2023-11-01125

OA

Role of prices in driving the variation in spending across medical groups

HEALTH SERVICES RESEARCH

IF3.2

2023-08-011

PRE

Editorial overview: Catalysis and regulation

CURRENT OPINION IN STRUCTURAL BIOLOGY

IF7

2020-12-010

PREAI

Characteristics Associated with Sulfonylureas and Basal Insulin Use following Metformin in Older Adults

IF7.5

2020-06-010

PRE

Comparative Rate of Amputations among Type 2 Diabetes Patients Starting Different SGLT2 Inhibitors

IF7.5

2020-06-010

PRE

Treatment Changes Post-Second-Line Medication Initiation, a Real-World Retrospective Cohort Study

IF7.5

2020-06-010

PRE

Health Care Use and Costs Among Patients With Nonalcoholic Steatohepatitis With Advanced Fibrosis Using the Fibrosis-4 Score

HEPATOLOGY COMMUNICATIONS

IF4.6

2020-05-2620

OAAI

Assessment of Adherence and Asthma Medication Ratio for a Once-Daily and Twice-Daily Inhaled Corticosteroid/Long-Acting β-Agonist for Asthma

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE

IF6.6

2019-05-0128

PREAI

Assessment of COPD-related outcomes in patients initiating a once daily or twice daily ICS/LABA

RESPIRATORY MEDICINE

IF3.1

2019-04-0112

OAAI

Comparison of healthcare resource utilization and costs in patients with type 2 diabetes initiating dapagliflozin versus sitagliptin

DIABETES OBESITY & METABOLISM

IF5.7

2018-09-107

PREAI

Burden of Illness Associated with Tenosynovial Giant Cell Tumors

CLINICAL THERAPEUTICS

IF3.6

2018-04-0116

OAAI

Real-world Study Characterizing Patients Prior to Receiving Albuterol Multidose Dry Powder Inhaler or Short-acting β2-Agonist Via Pressurized Metered-Dose Inhalers for Asthma and COPD in the United States

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

IF11.2

2018-02-010

OAAI

Predicting Hypertension Among Children With Incident Elevated Blood Pressure

ACADEMIC PEDIATRICS

IF2.8

2017-04-015

OAAI

Searching for the Smoker's Paradox in Acute Stroke Patients Treated With Intravenous Thrombolysis

NICOTINE & TOBACCO RESEARCH

IF3

2017-01-2819

PREAI

Change in Weight Status and Development of Hypertension

IF6.4

2016-03-0192

OAAI

Potential Misclassification of Blood Pressure Status in Children and Adolescents With Short or Tall Stature

AMERICAN JOURNAL OF EPIDEMIOLOGY

IF4.8

2015-12-085

OAAI

Proton pump inhibitor use by aspirin-treated coronary artery disease patients is not associated with increased risk of cardiovascular events

EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY

IF6.1

2015-09-0718

OA